Abstract
Biotechnology products offer both problems and opportunities for pharmacists. On one hand, they are expensive to purchase and keep on inventory. Typical compensation for outpatient prescriptions does not offset the cost of maintaining the inventory, or providing the education and training that patients often need to use biotechnology products properly. On the other hand, there are issues related to proper storage, preparation, and administration for which pharmacists are well prepared to address. Pharmacists are also convenient, trusted, and provide service at relatively low cost. Examples of special services that pharmacists can provide to improve the use of biotechnology products include patient education, injection clinics, provision of medical supplies, and predrawing syringes for patients. Patients are often sent to many providers for these services, resulting in inconvenience and fragmentation of care. If new compensation methods can be established to support more comprehensive pharmacy services, the use of biotechnology products by patients will improve.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 32-36 |
| Number of pages | 5 |
| Journal | Pharmacy practice management quarterly |
| Volume | 18 |
| Issue number | 2 |
| State | Published - 1998 |
| Externally published | Yes |
Fingerprint
Cite this
Reengineering the retail/ambulatory pharmacy for provision of biotechnology pharmaceutical services. / Schneider, Philip J.
In: Pharmacy practice management quarterly, Vol. 18, No. 2, 1998, p. 32-36.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Reengineering the retail/ambulatory pharmacy for provision of biotechnology pharmaceutical services.
AU - Schneider, Philip J
PY - 1998
Y1 - 1998
N2 - Biotechnology products offer both problems and opportunities for pharmacists. On one hand, they are expensive to purchase and keep on inventory. Typical compensation for outpatient prescriptions does not offset the cost of maintaining the inventory, or providing the education and training that patients often need to use biotechnology products properly. On the other hand, there are issues related to proper storage, preparation, and administration for which pharmacists are well prepared to address. Pharmacists are also convenient, trusted, and provide service at relatively low cost. Examples of special services that pharmacists can provide to improve the use of biotechnology products include patient education, injection clinics, provision of medical supplies, and predrawing syringes for patients. Patients are often sent to many providers for these services, resulting in inconvenience and fragmentation of care. If new compensation methods can be established to support more comprehensive pharmacy services, the use of biotechnology products by patients will improve.
AB - Biotechnology products offer both problems and opportunities for pharmacists. On one hand, they are expensive to purchase and keep on inventory. Typical compensation for outpatient prescriptions does not offset the cost of maintaining the inventory, or providing the education and training that patients often need to use biotechnology products properly. On the other hand, there are issues related to proper storage, preparation, and administration for which pharmacists are well prepared to address. Pharmacists are also convenient, trusted, and provide service at relatively low cost. Examples of special services that pharmacists can provide to improve the use of biotechnology products include patient education, injection clinics, provision of medical supplies, and predrawing syringes for patients. Patients are often sent to many providers for these services, resulting in inconvenience and fragmentation of care. If new compensation methods can be established to support more comprehensive pharmacy services, the use of biotechnology products by patients will improve.
UR - http://www.scopus.com/inward/record.url?scp=0032111592&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032111592&partnerID=8YFLogxK
M3 - Article
C2 - 10185237
AN - SCOPUS:0032111592
VL - 18
SP - 32
EP - 36
JO - Pharmacy practice management quarterly
JF - Pharmacy practice management quarterly
SN - 1080-5737
IS - 2
ER -